High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors (Q47564954)

4 February 2018

title

High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors (English)

1 reference

4 February 2018

author name string

J Rosenthal

1

1 reference

4 February 2018

E Bolotin

2

1 reference

4 February 2018

M Shakhnovits

3

1 reference

4 February 2018

A Pawlowska

4

1 reference

4 February 2018

P Falk

5

1 reference

4 February 2018

D Qian

6

1 reference

4 February 2018

C Oliver

7

1 reference

4 February 2018

J Sato

8

1 reference

4 February 2018

J Miser

9

1 reference

4 February 2018

S Forman

10

1 reference

4 February 2018

language of work or name

English

0 references

publication date

30 June 2008

1 reference

4 February 2018

Bone Marrow Transplantation

published in

1 reference

4 February 2018

volume

42

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

311-318

1 reference

4 February 2018

Survival after recurrence of Ewing's sarcoma family of tumors

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Curability of ewing's sarcoma and considerations for future therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Hematopoetic stem cell transplantation for solid tumors in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Treatment of peripheral neuroepithelioma in children and young adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Rapid-sequence tandem transplant for children with high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.169

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.169

1 reference

4 February 2018

1 reference

4 February 2018